BioVie Inc.
BIVI
$1.46
$0.053.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.43M | -18.48M | -17.54M | -18.99M | -24.27M |
| Total Depreciation and Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Total Amortization of Deferred Charges | 0.00 | 2.40K | 11.90K | -746.80K | 52.10K |
| Total Other Non-Cash Items | 2.38M | 2.65M | 2.67M | 4.46M | 4.19M |
| Change in Net Operating Assets | 498.70K | -2.88M | -4.40M | -2.37M | -2.22M |
| Cash from Operations | -14.32M | -18.47M | -19.03M | -17.42M | -22.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 2.90M | 2.90M | 2.90M | 2.90M | -- |
| Total Debt Repaid | 0.00 | -3.35M | -5.85M | -8.35M | -10.85M |
| Issuance of Common Stock | 10.46M | 26.77M | 18.58M | 18.58M | 37.05M |
| Repurchase of Common Stock | -2.90M | -2.90M | -2.90M | -2.90M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.46M | 23.42M | 12.73M | 10.23M | 26.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.86M | 4.95M | -6.30M | -7.20M | 4.18M |